Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Feb 24:7:220.
doi: 10.3389/fmicb.2016.00220. eCollection 2016.

Surface Proteoglycans as Mediators in Bacterial Pathogens Infections

Affiliations
Review

Surface Proteoglycans as Mediators in Bacterial Pathogens Infections

Beatriz García et al. Front Microbiol. .

Abstract

Infectious diseases remain an important global health problem. The interaction of a wide range of pathogen bacteria with host cells from many different tissues is frequently mediated by proteoglycans. These compounds are ubiquitous complex molecules which are not only involved in adherence and colonization, but can also participate in other steps of pathogenesis. To overcome the problem of microbial resistance to antibiotics new therapeutic agents could be developed based on the characteristics of the interaction of pathogens with proteoglycans.

Keywords: bacteria; glycosaminoglycans; host interaction; infection; proteoglycans.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Repeating disaccharide units of GAGs.
FIGURE 2
FIGURE 2
Heparan sulfate (HS) domain architecture. The highly sulfated NS-domains are flanked on either side by less-sulfated transition zones (NA/NS). In turn, these sulphated regions are separated by non-sulfated NA-domains.
FIGURE 3
FIGURE 3
Adhesion of bacterium to target cells mediated by HS and shedding of syndecan ectodomains. Schematic representation of the interaction between an adhesin on the outer membrane of a Gram negative bacteria and HS from syndecan on the cell surface of a eukaryotic.

References

    1. Armstrong R. A. (2000). The microbiology of the eye. Ophthalmic Physiol. Opt. 20 429–41. - PubMed
    1. Baldassarri L., Bertuccini L., Creti R., Filippini P., Ammendolia M. G., Koch S., et al. (2005). Glycosaminoglycans mediate invasion and survival of Enterococcus faecalis into Macrophages. J. Infect. Dis. 191 1253–1262. 10.1086/428778 - DOI - PubMed
    1. Barbier-Chassefière V., Garcia-Filipe S., Yue X. L., Kerros M. E., Petit E., Kern P., et al. (2009). Matrix therapy in regenerative medicine, a new approach to chronic wound healing. J. Biomed. Mater. Res. A 90 641–647. 10.1002/jbm.a.32124 - DOI - PubMed
    1. Barlett A. H., Park P. W. (2010). Proteoglycans in host-pathogen interactions: molecular mechanisms and therapeutic implications. Expert. Rev. Mol. Med. 12:e5 10.1017/S1462399409001367 - DOI - PMC - PubMed
    1. Bartlett A. H., Park P. W. (2011). “Heparan sulfate proteoglycans in infection,” in Glycans in Diseases and Therapeutics, ed. Paváo M. S. G. (Berlin: Springer Berlin Heidelberg; ), 31–62.

LinkOut - more resources